Evidence map›Paper›PMID 40102714›Full record

ArticleBMC medical research methodology2025

Using artificial intelligence for systematic review: the example of elicit.

Nathan Bernard, Yoshimasa Sagawa, Nathalie Bier, Thomas Lihoreau, Lionel Pazart, Thomas Tannou

Abstract read
In one paragraph

Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Implementation of artificial intelligence (AI) in ASD treatment.North American Spine Society journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nathan BernardInserm CIC 1431, CHU Besançon, Besançon, F-25000, France. nathan.bernard@univ-fcomte.fr.
Yoshimasa SagawaInserm CIC 1431, CHU Besançon, Besançon, F-25000, France.
Nathalie BierCentre de recherche de l'Institut universitaire de gériatrie de Montréal, CIUSSS Centre-sud-de l'île-de-Montréal, Montréal, Québec, Canada.
Thomas LihoreauInserm CIC 1431, CHU Besançon, Besançon, F-25000, France.
Lionel PazartInserm CIC 1431, CHU Besançon, Besançon, F-25000, France.
Thomas TannouInserm CIC 1431, CHU Besançon, Besançon, F-25000, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArtificial intelligence (AI) tools are increasingly being used to assist researchers with various research tasks, particularly in the systematic review process. Elicit is one such tool that can generate a summary of the question asked, setting it apart from other AI tools. The aim of this study is to determine whether AI-assisted research using Elicit adds value to the systematic review process compared to traditional screening methods.

methodsWe compare the results from an umbrella review conducted independently of AI with the results of the AI-based searching using the same criteria. Elicit contribution was assessed based on three criteria: repeatability, reliability and accuracy. For repeatability the search process was repeated three times on Elicit (trial 1, trial 2, trial 3). For accuracy, articles obtained with Elicit were reviewed using the same inclusion criteria as the umbrella review. Reliability was assessed by comparing the number of publications with those without AI-based searches.

resultsThe repeatability test found 246,169 results and 172 results for the trials 1, 2, and 3 respectively. Concerning accuracy, 6 articles were included at the conclusion of the selection process. Regarding, revealed 3 common articles, 3 exclusively identified by Elicit and 17 exclusively identified by the AI-independent umbrella review search.

conclusionOur findings suggest that AI research assistants, like Elicit, can serve as valuable complementary tools for researchers when designing or writing systematic reviews. However, AI tools have several limitations and should be used with caution. When using AI tools, certain principles must be followed to maintain methodological rigour and integrity. Improving the performance of AI tools such as Elicit and contributing to the development of guidelines for their use during the systematic review process will enhance their effectiveness.

Indexed as

Artificial IntelligenceSystematic Reviews as TopicHumansReproducibility of ResultsAccuracyArtificial intelligence toolsReliabilitySystematic review writing

Identifiers

PMID40102714
PMCPMC11921719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.